Cargando…

SERPINA1 mRNA as a Treatment for Alpha-1 Antitrypsin Deficiency

Alpha-1-antitrypsin (AAT) deficiency is a genetic disorder that produces inactive/defective AAT due to mutations in the SERPINA1 gene encoding AAT. This disease is associated with decreased activity of AAT in the lungs and deposition of excessive defective AAT protein in the liver. Currently there i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Connolly, Brendan, Isaacs, Cleo, Cheng, Lei, Asrani, Kirtika H., Subramanian, Romesh R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020464/ https://www.ncbi.nlm.nih.gov/pubmed/30009048 http://dx.doi.org/10.1155/2018/8247935

Ejemplares similares

Alternative transcripts of the SERPINA1 gene in alpha-1 antitrypsin deficiency
por: Matamala, Nerea, et al.
Publicado: (2015)

G6PC mRNA Therapy Positively Regulates Fasting Blood Glucose and Decreases Liver Abnormalities in a Mouse Model of Glycogen Storage Disease 1a
por: Roseman, Daniel S., et al.
Publicado: (2018)

Variants of SERPINA1 and the increasing complexity of testing for alpha-1 antitrypsin deficiency
por: Foil, Kimberly E.
Publicado: (2021)

A Novel SERPINA1 Mutation Causing Serum Alpha(1)-Antitrypsin Deficiency
por: Saunders, Darren N., et al.
Publicado: (2012)

Optimization of mRNA untranslated regions for improved expression of therapeutic mRNA
por: Asrani, Kirtika H., et al.
Publicado: (2018)

Exogenous alpha 1-antitrypsin down-regulates SERPINA1 expression
por: Karadagi, Ahmad, et al.
Publicado: (2017)

Known Mutations at the Cause of Alpha-1 Antitrypsin Deficiency an Updated Overview of SERPINA1 Variation Spectrum
por: Seixas, Susana, et al.
Publicado: (2021)

SERPINA1 and More? A Putative Genetic Contributor to Pulmonary Dysfunction in Alpha-1 Antitrypsin Deficiency
por: Jezela-Stanek, Aleksandra, et al.
Publicado: (2023)

Protein modeling to assess the pathogenicity of rare variants of SERPINA1 in patients suspected of having Alpha 1 Antitrypsin Deficiency
por: Kueppers, Friedrich, et al.
Publicado: (2019)

Evaluation of Alpha-1 Antitrypsin Levels and SERPINA1 Gene Polymorphisms in Sickle Cell Disease
por: Carvalho, Magda Oliveira Seixas, et al.
Publicado: (2017)

Clinical Significance of SERPINA1 Gene and Its Encoded Alpha1-Antitrypsin Protein in NSCLC
por: Ercetin, Evrim, et al.
Publicado: (2019)

Causal and Synthetic Associations of Variants in the SERPINA Gene Cluster with Alpha1-antitrypsin Serum Levels
por: Thun, Gian Andri, et al.
Publicado: (2013)

Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe bronchiectasis and pulmonary embolism
por: Milger, Katrin, et al.
Publicado: (2015)

Deficient and Null Variants of SERPINA1 Are Proteotoxic in a Caenorhabditis elegans Model of α1-Antitrypsin Deficiency
por: Cummings, Erin E., et al.
Publicado: (2015)

A combined in silico and in vitro study on mouse Serpina1a antitrypsin-deficiency mutants
por: Eggenschwiler, Reto, et al.
Publicado: (2019)

Alpha-1 Antitrypsin and Hepatocellular Carcinoma in Liver Cirrhosis: SERPINA1 MZ or MS Genotype Carriage Decreases the Risk
por: Rabekova, Zuzana, et al.
Publicado: (2021)

Population genetic testing and SERPINA1 sequencing identifies unidentified alpha-1 antitrypsin deficiency alleles and gene-environment interaction with hepatitis C infection
por: Schuler, Bryce A., et al.
Publicado: (2023)

Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
por: Callea, Francesco, et al.
Publicado: (2018)

mRNA treatment produces sustained expression of enzymatically active human ADAMTS13 in mice
por: Liu-Chen, Susan, et al.
Publicado: (2018)

Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin
por: Sosulski, Meredith L., et al.
Publicado: (2020)

Alpha-1 Antitrypsin as a Therapeutic Agent for Conditions not Associated with Alpha-1 Antitrypsin Deficiency
por: Wanner, Adam
Publicado: (2015)

In Vitro Investigations on Optimizing and Nebulization of IVT-mRNA Formulations for Potential Pulmonary-Based Alpha-1-Antitrypsin Deficiency Treatment †
por: Guan, Shan, et al.
Publicado: (2021)

Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
por: Petrache, Irina, et al.
Publicado: (2009)

Molecular characterization of PI(*)S(hangzhou), a SERPINA1 allele from continental China encoding a defective alpha-1-antitrypsin
por: Hernández-Pérez, José M., et al.
Publicado: (2022)

alpha1-Antitrypsin deficiency and hepatocellular cancer.
por: Kew, M. C., et al.
Publicado: (1978)

The prevalence of alpha-1 antitrypsin deficiency in Ireland
por: Carroll, Tomás P, et al.
Publicado: (2011)

Alpha-1 Antitrypsin Deficiency: The Learning Goes On
por: Stockley, Robert. A.
Publicado: (2020)

Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency
por: Belchamber, Kylie B R, et al.
Publicado: (2020)

Alpha-1 Antitrypsin Deficiency: Home Therapy
por: Annunziata, Anna, et al.
Publicado: (2021)

Global 5′-UTR RNA structure regulates translation of a SERPINA1 mRNA
por: Grayeski, Philip J, et al.
Publicado: (2022)

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
por: Chapman, Kenneth R, et al.
Publicado: (2018)

Structural characterization and conformational dynamics of alpha-1 antitrypsin pathogenic variants causing alpha-1-antitrypsin deficiency
por: Shaik, Noor Ahmad, et al.
Publicado: (2022)

Prevalence of genetic polymorphisms in the promoter region of the alpha-1 antitrypsin (SERPINA1) gene in chronic liver disease: a case control study
por: Kok, Karin F, et al.
Publicado: (2010)

Autophagy master regulator TFEB induces clearance of toxic SERPINA1/α-1-antitrypsin polymers
por: Pastore, Nunzia, et al.
Publicado: (2013)

alpha 1-Antitrypsin deficiency and susceptibility to lung disease.
por: Evans, H E, et al.
Publicado: (1979)

Alpha 1 Antitrypsin Deficiency in Infants with Neonatal Cholestasis
por: Monajemzadeh, Maryam, et al.
Publicado: (2013)

Cardiovascular risk in patients with alpha-1-antitrypsin deficiency
por: Fähndrich, Sebastian, et al.
Publicado: (2017)

The Importance of Early Identification of Alpha-1 Antitrypsin Deficiency
por: Buttar, Barjinder S, et al.
Publicado: (2018)

Severe bilateral descemetoceles in Alpha-1 antitrypsin deficiency
por: Ma, Jeffrey, et al.
Publicado: (2019)

Alpha-1 Antitrypsin Deficiency and COVID-19 Infection
por: Strassmair, Michael, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ap7q3vvrt9vu2qh256qrobo4dn